RHYTHM Biosciences Ltd (RHY) — Financial Flexibility Index
RHYTHM Biosciences Ltd (RHY) has a Financial Flexibility Index of -2.33x as of December 2025. Free cash flow of AU$-2.22 Million (operating CF AU$-2.22 Million minus capex AU$1.02K) represents -2% of total liabilities (AU$955.41K). Check RHYTHM Biosciences Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
RHYTHM Biosciences Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for RHYTHM Biosciences Ltd across 9 annual periods. For the full cash flow conversion analysis, see RHYTHM Biosciences Ltd (RHY) cash conversion ratio.
Annual Financial Flexibility Index for RHYTHM Biosciences Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for RHYTHM Biosciences Ltd. Explore RHYTHM Biosciences Ltd (RHY) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.33x | AU$-2.90 Million | AU$-2.92 Million | AU$2.17 Million | ▲ +85.6% |
| 2024 | -9.29x | AU$-6.05 Million | AU$-6.14 Million | AU$651.54K | ▼ -146.7% |
| 2023 | -3.77x | AU$-6.86 Million | AU$-6.96 Million | AU$1.82 Million | ▲ +35.1% |
| 2022 | -5.81x | AU$-6.19 Million | AU$-6.21 Million | AU$1.07 Million | ▼ -48.4% |
| 2021 | -3.91x | AU$-5.33 Million | AU$-5.40 Million | AU$1.36 Million | ▼ -16.5% |
| 2020 | -3.36x | AU$-2.70 Million | AU$-2.74 Million | AU$802.85K | ▲ +54.9% |
| 2019 | -7.46x | AU$-2.83 Million | AU$-2.94 Million | AU$379.71K | ▲ +18.0% |
| 2018 | -9.10x | AU$-1.34 Million | AU$-1.65 Million | AU$147.38K | ▼ -10804.0% |
| 2017 | 0.08x | AU$10.75K | AU$-13.00 | AU$126.48K | — |